期刊文献+

代谢综合征患者120例临床分析

下载PDF
导出
摘要 目的探讨代谢综合征的临床特点及与冠心病的关系。方法研究对象为2005年11月~2006年6月本院心血管内科住院病人中符合代谢综合征诊断标准的120例患者(其中50例患者行冠脉造影检查)测量其腰围、脖围、血压、空腹甘油三脂(TG)、空腹高密度胆固醇(HDL-C)、空腹血糖(FPG)、餐后2h血糖(2hPG)以及尿酸、hsCRP等生化指标,并登记询问其生活习惯,家族史等情况,然后对结果进行统计学分析。另外选取50例健康成人(男30例,女20例)作为对照组测量脖围。结果住院病人中男性患者84例(69.90%),女性患者36例(30.10%),其中大部分不运动或少量运动(82.52%);男性患者的腰围均值为(98.69±6.46)cm,脖围均值为(39.71±5.31)cm,女性患者腰围均值为(96.40±4.19)cm,脖围均值为(35.75±1.93)cm;男性对照组脖围为(36.71±1.79)cm,女性为(33.22±2.06)cm,P<0.05。在50例行冠脉造影的患者中,冠脉造影阳性患者35例(70.27%),冠脉造影阳性者合并糖尿病或糖耐量异常者19例(38.46%),冠脉造影阴性合并糖尿病或糖耐量异常者3例(18.18%);随着代谢综合征病程的延长,冠脉造影阳性率逐渐升高,P<0.05。结论男性患者代谢综合征患病率高于女性患者,代谢综合征患者冠心病的发病率明显高于非代谢综合征者,脖围可能是一个简易的预测代谢综合征的指标。
出处 《江西医药》 CAS 2006年第9期667-670,共4页 Jiangxi Medical Journal
  • 相关文献

参考文献11

  • 1宋秀霞 ,纪立农 .国际糖尿病联盟代谢综合征全球共识定义[J].中华糖尿病杂志(1006-6187),2005,13(3):178-180. 被引量:610
  • 2Liubov (Louba) Ben-Noun,Arie Laor.Relationship of Neck Circumference to Cardiovascular Risk Factors.Obesity Research,2003,11:226
  • 3Reaven G M,Banting Lecture.Role of Insulin Resistance in Human Disease.Diabetes,1988,37:1595
  • 4Ninomiya J K,L'Italien G,Criqui M H,et al.Association of the Metabolic Syndrome with History of Myocardial Infarction and Stroke in the Third National Health and Nutrition Examination Survey.Circulation,2004,109:42
  • 5Eckel RH,Krauss RM.American heart association call to action:obesity as a major risk factor for coronary heart disease:AHA nutrition committee.Circulation,1998,97:2099
  • 6Nieves DJ,Cnop M,Retzlaff B,et al.The atherogenic lipoprotein profile associated with obesity and insulin resistance is largely attributable to intra-abdominal fat.Diabetes,2003,52:172
  • 7Anders H.Berg,Philipp E.Adipose Tissue,Inflammation,and Cardiovascular Disease.Citc Res,2005,96:939
  • 8Manninen V,Tenkanen L,Koskinen P,et al.Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study.Implications for treatment.Circulation,1992,85:37
  • 9Moller DE,Berger JP.Role of PPARs in the regulation of obesityrelated insulin sensitivity and inflammation.Int J Obes Relat Metab Disord,2003,27:17
  • 10Skurk T,Havner H.Obesity and impaired fibrinolysis:role of adipose production of plasminogen activator inhibitor-1.Int J Obes Relat Metab Disord,2004,28:1357

二级参考文献22

  • 1Nesto RW. The relation of insulin resistance syndromes to risk of cardiovascular disease. Rev Cardiovasc Med,2003,4(suppl 6):s11-s18.
  • 2Pouliot MC, Després JP, Lemieux S, et al. Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am J Cardiol,1994,73:460-468.
  • 3Brunzell JD, Ayyobi AF. Dyslipidemia in the metabolic syndrome and type 2 diabetes mellitus. Am J Med,2003,115(suppl 8A):24s-28s.
  • 4Robins SJ, Rubins HB, Faas FH, et al. Insulin resistance and cardiovascular events with low HDL cholesterol. The Veterans Affairs HDL Intervention Trial (VA-HIT). Diabetes Care,2003,26:1513-1517.
  • 5Steinmetz A, Fenselau S, Schrezenmeir J. Treatment of dyslipoproteinemia in the metabolic syndrome. Exp Clin Endocrinol Diabetes,2001,109:s548-559.
  • 6Robins SJ, Collins D, Wittes JT, et al. Relation of gemfibrozil treatment and lipid levels with major coronary events: VA-HIT: a randomized controlled trial. JAMA, 2001,285:1585-1591.
  • 7Tan CE, Ma S, Wai D, et al. Can we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians? Diabetes Care, 2004,27:1182-1186.
  • 8Lindstrom J, Louheranta A, Mannelin M. The Finnish Diabetes Prevention Study (DPS): Lifestyle intervention and 3-year results on diet and physical activity. Diabetes Care, 2003,26:3230-3236.
  • 9Tuomilehto J, Lindstrm J, Eriksson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. NEJM, 2001,344:1343-1350.
  • 10Heart Protection Study Collaborative Group, MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. Lancet,2003,361:2005-2016.

共引文献609

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部